These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 21315276)
21. Development of Semiautomated Module for Preparation of Mukherjee A; Subramanian S; Ambade R; Avhad B; Dash A; Korde A Cancer Biother Radiopharm; 2017 Feb; 32(1):33-37. PubMed ID: 28128645 [TBL] [Abstract][Full Text] [Related]
22. Thyroid uptake and radiation dose after (131)I-lipiodol treatment: is thyroid blocking by potassium iodide necessary? Bacher K; Brans B; Monsieurs M; De Winter F; Dierckx RA; Thierens H Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1311-6. PubMed ID: 12271412 [TBL] [Abstract][Full Text] [Related]
23. Automation of labelling of Lipiodol with high-activity generator-produced 188Re. Lepareur N; Ardisson V; Noiret N; Boucher E; Raoul JL; Clément B; Garin E Appl Radiat Isot; 2011 Feb; 69(2):426-30. PubMed ID: 21106381 [TBL] [Abstract][Full Text] [Related]
24. Combining iodine-131 Lipiodol therapy with low-dose cisplatin as a radiosensitiser: preliminary results in hepatocellular carcinoma. Brans B; Van Laere K; Gemmel F; Defreyne L; Vanlangenhove P; Troisi R; Van Vlierberghe H; Colle I; De Hemptinne B; Dierckx RA Eur J Nucl Med Mol Imaging; 2002 Jul; 29(7):928-32. PubMed ID: 12111134 [TBL] [Abstract][Full Text] [Related]
25. 188Re-SSS lipiodol: radiolabelling and biodistribution following injection into the hepatic artery of rats bearing hepatoma. Garin E; Denizot B; Noiret N; Lepareur N; Roux J; Moreau M; Herry JY; Bourguet P; Benoit JP; Lejeune JJ Nucl Med Commun; 2004 Oct; 25(10):1007-13. PubMed ID: 15381868 [TBL] [Abstract][Full Text] [Related]
26. Rhenium-188 based radiopharmaceuticals for treatment of liver tumours. Lambert B; Bacher K; Defreyne L Q J Nucl Med Mol Imaging; 2009 Jun; 53(3):305-10. PubMed ID: 19521309 [TBL] [Abstract][Full Text] [Related]
27. Synthesis of 188 Re-labelled long chain alkyl diaminedithiol for therapy of liver cancer. Lee YS; Jeong JM; Kim YJ; Chung JW; Park JH; Suh YG; Lee DS; Chung JK; Lee MC Nucl Med Commun; 2002 Mar; 23(3):237-42. PubMed ID: 11891481 [TBL] [Abstract][Full Text] [Related]
28. Biokinetic and dosimetric studies of 188Re-hyaluronic acid: a new radiopharmaceutical for treatment of hepatocellular carcinoma. Meléndez-Alafort L; Nadali A; Zangoni E; Banzato A; Rondina M; Rosato A; Mazzi U Nucl Med Biol; 2009 Aug; 36(6):693-701. PubMed ID: 19647176 [TBL] [Abstract][Full Text] [Related]
29. Rhenium-188: availability from the (188)W/(188)Re generator and status of current applications. Pillai MR; Dash A; Knapp FF Curr Radiopharm; 2012 Jul; 5(3):228-43. PubMed ID: 22642385 [TBL] [Abstract][Full Text] [Related]
30. Treatment of unresectable hepatocellular carcinoma with transarterial radioembolization: iodine-131-lipiodol. Lau WY; Lai EC ANZ J Surg; 2008 May; 78(5):331-2. PubMed ID: 18380721 [No Abstract] [Full Text] [Related]
31. 188rhenium-TDD-lipiodol in treatment of inoperable primary hepatocellular carcinoma--a case report. Sundram FX; Yu SW; Jeong JM; Somanesan S; Premaraj J; Saw MM; Tan BS Ann Acad Med Singap; 2001 Sep; 30(5):542-5. PubMed ID: 11603144 [TBL] [Abstract][Full Text] [Related]
32. International Atomic Energy Agency-sponsored multination study of intra-arterial rhenium-188-labeled lipiodol in the treatment of inoperable hepatocellular carcinoma: results with special emphasis on prognostic value of dosimetric study. Bernal P; Raoul JL; Stare J; Sereegotov E; Sundram FX; Kumar A; Jeong JM; Pusuwan P; Divgi C; Zanzonico P; Vidmar G; Buscombe J; Chau TT; Saw MM; Chen S; Ogbac R; Dondi M; Padhy AK Semin Nucl Med; 2008 Mar; 38(2):S40-5. PubMed ID: 18243842 [TBL] [Abstract][Full Text] [Related]
33. Adjuvant intraarterial injection of 131I-labeled lipiodol after resection of hepatocellular carcinoma: progress report of a case-control study with a 5-year minimal follow-up. Boucher E; Bouguen G; Garin E; Guillygomarch A; Boudjema K; Raoul JL J Nucl Med; 2008 Mar; 49(3):362-6. PubMed ID: 18287267 [TBL] [Abstract][Full Text] [Related]
37. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245 [TBL] [Abstract][Full Text] [Related]
38. Therapy of hepatocellular carcinoma with iodine-131-lipiodol. Results in a large German cohort. Risse JH; Rabe C; Pauleit D; Reichmann K; Menzel C; Grünwald F; Strunk H; Biersack HJ; Palmedo H Nuklearmedizin; 2006; 45(4):185-92. PubMed ID: 16964345 [TBL] [Abstract][Full Text] [Related]
39. Preoperative treatment of hepatocellular carcinoma with intra-arterial injection of 131I-labelled lipiodol (Br J Surg 2003; 90: 1379-1383). Rai R; Rai S Br J Surg; 2004 Mar; 91(3):373; author reply 373. PubMed ID: 14991642 [No Abstract] [Full Text] [Related]
40. Preparation and in vitro evaluation of B-lipiodol as a boron delivery agent for neutron capture therapy of hepatoma. Chou FI; Lui WY; Wei YY; Chung RJ; Kai JJ; Chi CW Anticancer Res; 1999; 19(3A):1759-64. PubMed ID: 10470112 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]